Specifically, we used stratified analyses by time from blood draw to diagnosis to address whether differences in AHRR methylation levels could provide a long-term marker of NHL susceptibility or instead reflect a response to tumor growth prior to diagnosis. Here, AHRR is linked to non-Hodgkin lymphoma.